Loading...

Biotest AG

BIO.DE•XETRA
Healthcare
Biotechnology
€42.20
€-0.40(-0.94%)

Biotest AG (BIO.DE) Stock Overview

Explore Biotest AG’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 71.2/100

Key Financials

Market Cap1.4B
P/E Ratio63.25
EPS (TTM)$-0.63
ROE0.05%
Fundamental Analysis

AI Price Forecasts

1 Week$42.49
1 Month$43.53
3 Months$41.43
1 Year Target$41.16

BIO.DE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Biotest AG (BIO.DE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 39.38, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $41.16.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 63.25 and a market capitalization of 1.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;